Telemonitoring platform for high-risk chronic kidney disease patients
Official title: A Pragmatic Randomized Controlled Trial of a CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
Run by University of Manitoba · NCT05726526 · Data updated 2026-11-12
This study is testing if a new virtual care platform can help people with advanced kidney disease stay healthier and avoid trips to the emergency room or hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 340 (estimated) |
| Sponsor | University of Manitoba Academic / other |
| Locations | 5 sites (Winnipeg, Manitoba and 4 other locations) |
| Status | Recruiting |
| Started | June 30, 2022 |
| Main results expected | March 30, 2027 |
| Study ends | March 30, 2028 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT05726526 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with stage 5 CKD who are capable of using the VIEWER platform and have a high risk of starting dialysis within the next two years.
✕Probably not a fit
Patients who are unable to perform self-monitoring or use the VIEWER application may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial aims to evaluate the effectiveness of the VIEWER virtual care platform in reducing emergency department visits and hospitalizations among patients with advanced chronic kidney disease (CKD) stage 5. The study will involve a multicenter randomized controlled design across five sites in Canada, where patients will use the VIEWER platform to monitor their health metrics, such as blood pressure and weight. By facilitating better communication between patients and healthcare providers, the trial seeks to optimize the transition to dialysis and improve patient safety during this critical period.
Why it matters
Potential benefit: If successful, this approach could significantly reduce hospital visits and enhance the management of patients transitioning to dialysis.
How similar studies have gone: Other studies have shown promise in using telemonitoring for chronic conditions, suggesting that this approach could be beneficial, although the specific application for CKD is still being explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years of age * Patient or primary caregiver can read and speak English * Patient or patients substitute decision maker is able to provide informed consent * Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.) * Have stage 5 CKD (2 measurements of eGFR \<15ml/min/1.73m2); eGFR will be calculated with the CKD-EPI equation, or have \>40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation * Followed in a multidisciplinary CKD clinic Exclusion Criteria: * Inability of self or caregiver assisted self-monitoring using VIEWER
Where it's running
-
St. Boniface Hospital
Winnipeg, Manitoba, Canada Recruiting -
Chronic Disease Innovation Centre, Seven Oaks Hospital
Winnipeg, Manitoba, Canada Recruiting -
Health Sciences Centre
Winnipeg, Manitoba, Canada Recruiting -
London Health Sciences Centre
London, Ontario, Canada Recruiting -
Scarborough Health Network - General Hospital
Scarborough Village, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Claudio Rigatto, MD — University of Manitoba
- Study coordinator: Claudio Rigatto, MD
- Email: crigatto@sogh.mb.ca
- Phone: 204-631-3834
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ribupatide PK in People with Kidney Impairment
This study tests how a single shot of ribupatide behaves in the body for people with severe kidney problems compared to those with normal kidney function.
-
Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease
This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.
-
Pumpkin seed oil for people on hemodialysis
This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.
-
Porcine thymokidney transplant for end-stage renal disease
This study tests whether a GalKO porcine thymokidney transplant can keep kidney function without dialysis in adults with end-stage kidney disease who are unlikely to get a standard donor kidney soon.
-
Home-based exercise to boost fitness for people waiting for a kidney transplant
This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.
-
How inflammatory diseases change the way your body handles medicines.
This study will see if inflammatory conditions like type 2 diabetes, IBD, or end-stage kidney disease change how common medicines are processed and increase the chance of side effects.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.